Neo Borocillina Gola Dolore (Flurbiprofen)

Flurbiprofen works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels lead to decreased inflammation, pain, and swelling in the oropharyngeal tissues.

The exact dose and frequency are determined by the prescribing healthcare professional based on the severity of symptoms, patient age, and clinical judgment. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety in pregnancy and lactation has not been fully established for flurbiprofen used in this form. Healthcare providers should weigh potential benefits against risks and consider alternative treatments when treating pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Flurbiprofen offers a potent anti‑inflammatory effect with rapid onset when applied locally to the throat, which can be advantageous over systemic NSAIDs that may require higher systemic exposure. Its topical route limits systemic side effects but still shares class‑related risks such as gastrointestinal irritation.

Neo Borocillina Gola Dolore should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

The product is intended for oropharyngeal use. The prescribed amount is applied directly to the affected area of the throat, typically by spraying or swabbing as directed by the healthcare professional. Patients should avoid swallowing large volumes and follow the administration instructions carefully.

Serious risks include gastrointestinal ulceration or bleeding, severe allergic reactions such as anaphylaxis, renal impairment, and rare but severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as vomiting blood, severe rash, or sudden kidney problems.

Individuals with known hypersensitivity to flurbiprofen or any NSAID, those with active gastrointestinal ulcer disease, severe renal or hepatic impairment, and patients taking anticoagulants or other drugs that significantly increase bleeding risk should avoid using this product unless specifically advised by a physician.